- Home
- DTI vs ABOS Comparison
DTI vs ABOS Comparison
Compare DTI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTI
- ABOS
- Stock Information
- Founded
- DTI 1984
- ABOS 1996
- Country
- DTI United States
- ABOS United States
- Employees
- DTI N/A
- ABOS N/A
- Industry
- DTI Metal Fabrications
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- DTI Industrials
- ABOS Health Care
- Exchange
- DTI Nasdaq
- ABOS Nasdaq
- Market Cap
- DTI 68.0M
- ABOS 66.6M
- IPO Year
- DTI N/A
- ABOS 2021
- Fundamental
- Price
- DTI $2.62
- ABOS $1.02
- Analyst Decision
- DTI Strong Buy
- ABOS Strong Buy
- Analyst Count
- DTI 1
- ABOS 3
- Target Price
- DTI $5.50
- ABOS $7.33
- AVG Volume (30 Days)
- DTI 56.0K
- ABOS 201.3K
- Earning Date
- DTI 05-13-2025
- ABOS 05-13-2025
- Dividend Yield
- DTI N/A
- ABOS N/A
- EPS Growth
- DTI N/A
- ABOS N/A
- EPS
- DTI N/A
- ABOS N/A
- Revenue
- DTI $160,352,000.00
- ABOS N/A
- Revenue This Year
- DTI $4.26
- ABOS N/A
- Revenue Next Year
- DTI $6.26
- ABOS N/A
- P/E Ratio
- DTI N/A
- ABOS N/A
- Revenue Growth
- DTI 8.19
- ABOS N/A
- 52 Week Low
- DTI $1.43
- ABOS $0.86
- 52 Week High
- DTI $6.36
- ABOS $3.60
- Technical
- Relative Strength Index (RSI)
- DTI 57.72
- ABOS 46.87
- Support Level
- DTI $2.34
- ABOS $0.99
- Resistance Level
- DTI $2.79
- ABOS $1.06
- Average True Range (ATR)
- DTI 0.23
- ABOS 0.06
- MACD
- DTI 0.02
- ABOS 0.00
- Stochastic Oscillator
- DTI 70.69
- ABOS 41.18
About DTI Drilling Tools International Corporation
Drilling Tools International Corp manufactures, rents, inspects, and refurbishes downhole drilling tools primarily to companies in the oil and natural gas industry for bottom hole assemblies used in onshore and offshore horizontal and directional drilling. The company's United States operations have locations in Texas, California, Louisiana, Oklahoma, Pennsylvania, North Dakota, New Mexico, Utah, and Wyoming. The company's single segment derives revenues from customers by providing oilfield equipment and services to operators in the oil and natural gas sectors.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.